-
稳定性冠心病诊断与治疗指南中华医学会心血管病学分会介入心脏病学组, 中华医学会心血管病学分会动脉粥样硬化与冠心病学组, 中国医师协会心血管内科医师分会血栓防治专业委员会, 等. -
Defining Staged Procedures for Percutaneous Coronary Intervention Trials A Guidance DocumentE Spitzer, E Mc Fadden, P Vranckx et al.
-
Interleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and BeyondLibby P
-
Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trialDC Wheeler, BV Stefánsson, DAPA-CKD Trial Committees and Investigators et al.
-
Randomized Trial Evaluating Percutaneous Coronary Intervention for the Treatment of Chronic Total Occlusion: The DECISION-CTO TrialLee SW, Lee PH, Park SJ et al.
-
The Astronaut Cardiovascular Health and Risk Modification (Astro-CHARM) Coronary Calcium Atherosclerotic Cardiovascular Disease Risk CalculatorA Khera , MJ Budoff , CJ O’Donnell et al.
-
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and AdolescentsFlynn JT, Kaelber DC, Baker-Smith CM et al.
-
10-Year Coronary Heart Disease Risk Prediction Using Coronary Artery Calcium and Traditional Risk Factors: Derivation in the MESA (Multi-Ethnic Study of Atherosclerosis) With Validation in the HNR (Heinz Nixdorf Recall) Study and the DHS (Dallas Heart Study)McClelland RL, Jorgensen NW, Budoff M et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
